tirzepatide vs semaglutide weight loss studies GLP-1 Medications for Loss: vs Retat – Revolution Health & Wellness Weight Loss Shots | Cordova

These medications have helped many people lose weight when other approaches fail

Ozempic and diverticulitis When digestion slows down, constipation can occur

Tirzepatide is now approved for treating obstructive sleep apnea

Novo Nordisk was filed on December 15, 2023

According to the International Diabetes Federation (IDF), 589 million adults (20-79 years) are living with diabetes, and in 2024, statistics show that diabetes alone caused 3.4 million deaths

Pipeline and Future Trials Novo Nordisk's pediatric development program for semaglutide includes ongoing studies listed on ClinicalTrials.gov, though enrollment criteria and timelines shift